Live Farm Cam
Live Farm Cam

Does Medicare Cover CBD? The Complete Guide

Written by the Edify Wellness Team

Yes. Medicare does cover CBD products for eligible patients through a federally authorized program called the Substance Access Beneficiary Engagement Incentive, or BEI. This program lets participating Accountable Care Organizations (ACOs) provide up to $500 per year in qualifying CBD products to eligible Medicare patients at no cost to the patient.

This isn't a rumor or a gray area. The Centers for Medicare & Medicaid Services (CMS) built the BEI directly into value-based care models as a tool to support patients managing chronic pain, cancer symptoms, and other serious conditions. If your doctor participates in one of these ACO programs, you may already qualify.

This guide covers everything you need to know: who qualifies, what products count, how the program works, and why Edify's products are designed to meet every CMS compliance requirement. Keep reading, or jump to the section that matters most to you.

Quick Facts About Medicare CBD Coverage

  • The benefit is up to $500 per year in qualifying CBD products per eligible patient
  • Products must be orally administered, hemp-derived, and third-party tested
  • Delta-9 THC must be 0.3% or less, and no more than 3mg total THC per serving
  • Only available through a participating ACO (you can't buy retail CBD and get reimbursed)
  • The program covers all 50 states through 74 participating ACO REACH organizations

What Is the Medicare CBD Program?

The Substance Access BEI is part of the CMS Innovation Center's push to expand value-based care options. It operates within two active models: the ACO REACH Model and the Enhancing Oncology Model. A third model, the LEAD Model, is expected to join.

Here's the basic structure: participating ACOs choose to offer qualifying CBD products as a supplemental benefit. A doctor within that ACO documents a shared decision-making visit with the patient, covering benefits, risks, the patient's goals, their current medications, and a plan for follow-up. After that visit, the patient can receive the products through the ACO.

The ACO absorbs the cost. There's no billing code for CBD under Medicare Part D, and patients can't submit receipts. The entire process flows through the ACO's own benefit design.

This is genuinely new territory for Medicare. Historically, Medicare hasn't covered any plant-based wellness products outside of limited exceptions. The BEI changes that for hemp-derived CBD with strict quality controls in place.

Who Qualifies for the Medicare CBD Benefit?

Not every Medicare patient is automatically eligible. Eligibility depends on a few things:

  • Your doctor must be part of a participating ACO (ACO REACH or Enhancing Oncology Model)
  • Your doctor must complete a documented shared decision-making visit with you
  • You must not have a disqualifying condition (the program excludes patients with substance use disorder or COPD, among others)

If you're not sure whether your doctor participates, the best step is to ask directly at your next appointment. You can also review the full eligibility breakdown on our Medicare CBD eligibility page.

The program is available across all 50 states through 74 ACO REACH organizations. That's a wide reach, and it means most Medicare patients in urban and suburban areas have a realistic path to accessing the benefit.

What CBD Products Qualify Under Medicare?

CMS has set clear product requirements. Products must be:

  • Orally administered (gummies, tinctures, capsules; no vapes, no topicals under this benefit)
  • Hemp-derived
  • 0.3% or less delta-9 THC
  • 3mg or less total THC per serving
  • Third-party tested for potency, contaminants, and microbial hazards

Inhalable products are excluded entirely. So are synthetic cannabinoids. The program is built around safe, lab-verified, plant-based oral products.

For a full breakdown of what qualifies and why, see our approved Medicare CBD products page.

Why Edify Fits the BEI Rules

Edify's products were built with exactly this kind of scrutiny in mind. Every product we make goes through independent third-party lab testing, and we publish the results publicly so you can verify compliance yourself. Our hemp is grown on our family farm in Kentucky through a Seed-to-Self process that gives us full visibility from planting to packaging.

Here's how our qualifying products stack up against CMS requirements:

BEI Requirement Edify Compliance
Oral administration only Yes. Gummies and tinctures (taken by mouth)
Hemp-derived Yes. Kentucky-grown hemp, Seed-to-Self
0.3% or less delta-9 THC Yes. Every batch tested and verified
3mg or less total THC per serving Yes. Lab results confirm compliance
Third-party tested Yes. Independent lab testing with public COAs
No inhalable products Correct. Our qualifying products are all oral
No synthetic cannabinoids Correct. All-natural, plant-based formulations

You can view every lab report on our lab results and COA page. You can also learn more about how we grow and process our hemp on our Seed-to-Self page.

Edify Products That May Qualify

The following Edify products are orally administered, hemp-derived, and third-party tested to meet CMS compliance thresholds:

If you'd like to save on your order, our Subscribe & Save program is available for direct purchases as well.

How the Program Works, Step by Step

Understanding the mechanics helps you know what to expect and what to ask your doctor. Here's how the BEI process typically works:

  1. Your ACO opts in. Not every ACO participates, but 74 organizations across all 50 states currently do.
  2. Your doctor completes a shared decision-making visit. This visit is documented and covers the specific topics CMS requires.
  3. You receive the products through the ACO. You don't buy them at retail. The ACO furnishes them directly.
  4. The ACO absorbs the cost. There's no patient copay, no claim to file, no reimbursement process for you.

For a deeper look at how the whole system fits together, see our full explanation of how the Medicare CBD program works.

The Regulatory Picture

This program didn't appear out of nowhere. Several regulatory steps led here. The FDA issued an enforcement discretion memo stating it won't enforce certain prohibitions on oral CBD products used within the BEI program. CMS designed the BEI with specific product thresholds to make sure only well-tested products qualify.

There is active litigation. An organization called Smart Approaches to Marijuana (SAM) filed a lawsuit to block the program. The program continues to operate while that case works through the courts. CMS has also stated it will adjust program rules as federal hemp law evolves.

For the latest on program developments and regulatory changes, visit our Medicare CBD news and updates page.

Common Questions

We've put together answers to the most common questions patients ask about the Medicare CBD benefit. You'll find the full list on our Medicare CBD FAQ page, but here are a few of the big ones:

Can I just buy CBD at a store and get reimbursed by Medicare?
No. Medicare doesn't reimburse retail CBD purchases. The products must be furnished through the ACO.

Does my Medicare Advantage plan cover CBD?
Medicare Advantage plans operate differently than traditional Medicare. Some plans may offer supplemental benefits that include CBD, but that's separate from the BEI program. Check your plan's evidence of coverage.

What if my doctor doesn't participate?
Ask your doctor if their practice is affiliated with an ACO REACH organization. If not, you can ask about switching to a participating provider.

Medicare CBD Coverage by State

The BEI program covers all 50 states. Here are a few of the most-searched state pages to get you started:

Why Edify?

There are plenty of CBD brands. Here's what makes Edify different, and why it matters specifically for patients navigating this program:

We grow our own hemp. Our family farm in Kentucky produces all the hemp that goes into our products. That's not common in this industry. Most brands buy raw material from third-party farms with little visibility into growing practices.

We test everything. Independent labs test every batch for potency, contaminants, pesticides, and microbial hazards. Results are published publicly on our lab results page. You can verify compliance before you ever place an order.

Our formulas are clean. No melatonin, no artificial dyes, no synthetic fillers. Plant-based and vegan. We use nano-enhanced CBD technology to improve bioavailability, so more of what you take actually reaches your system.

We operate Seed-to-Self. From planting on our USDA-certified organic farm to the final product in your hands, we control every step. Learn more about our process on our farm page.

What to Do Next

If you're a Medicare patient and want to explore this benefit:

  1. Ask your doctor if their practice participates in an ACO REACH program
  2. Request a shared decision-making visit focused on CBD as a supplement to your care plan
  3. Review the eligible products with your doctor and compare options

If you want to purchase Edify products directly while waiting for ACO access, all of our qualifying products are available at edifyone.com. Our Subscribe & Save program can reduce your per-order cost.

If you have more questions, our FAQ page covers the most common ones. And if you want the latest on regulatory developments, check our news page.

Shop Edify CBD & Wellness Products

Medicare CBD Resources

Are you age 21+?

By entering this site you are agreeing to the Terms of Use and Privacy Policy.